Brief: Magenta Therapeutics Reports Quarterly Loss Per Share $0.29

Dianthus Therapeutics

04/08/2022 14:38

Aug 4 (Reuters) - Magenta Therapeutics Inc  MGTA.O :
    * MAGENTA THERAPEUTICS REPORTS SECOND QUARTER FINANCIAL
RESULTS
AND RECENT PROGRAM HIGHLIGHTS
    * MAGENTA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.29
    * MAGENTA THERAPEUTICS INC - ANTICIPATES CASH, EQUIVALENTS
WILL BE
SUFFICIENT TO FUND ITS CURRENT OPERATIONAL PLAN INTO Q2 2024

Source text for Eikon:  ID:nGNX6kBSLx 
Further company coverage:  MGTA.O 

 ((Reuters.Briefs@thomsonreuters.com;))